Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000929638-26-000098·Aclaris Therapeutics, Inc.
Schedule 13G ownership disclosure
Aclaris Therapeutics Inc
Common Stock, $0.00001 par value · CUSIP: 00461U105
Event date: 2025-12-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Biosion, Inc.
Shares: 11,281,950 · Class: 9.4%
- Bonita Biotech (HK) Ltd
Shares: 11,281,950 · Class: 9.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-26-000098
- Form type
- SCHEDULE 13G/A
- Filer
- Aclaris Therapeutics, Inc.
- CIK
- CIK 1557746
- Filed
- Jan 09, 2026
- Reporting period
- Dec 09, 2025
- Description
- Schedule 13G beneficial ownership